SNP Genotyping Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The SNP Genotyping and Analysis Market Report is Segmented by Technology (TaqMan SNP Genotyping, Massarray SNP Genotyping, SNP GeneChip Arrays, and Other Techniques), Usage (Pharmacogenomics and Diagnostic Field), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The Report Offers the Value (in USD) for the Above Segments.

SNP Genotyping Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

SNP Genotyping Market Size

SNP Genotyping Market Summary
Study Period 2022 - 2030
Market Size (2025) USD 7.44 Billion
Market Size (2030) USD 19.33 Billion
CAGR (2025 - 2030) 21.03 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

SNP Genotyping Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of SNP Genotyping Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

SNP Genotyping Market Analysis

The SNP Genotyping Market size is estimated at USD 7.44 billion in 2025, and is expected to reach USD 19.33 billion by 2030, at a CAGR of 21.03% during the forecast period (2025-2030).

The SNP genotyping market is driven by the miniaturization of equipment and instruments, significant applications of SNP genotyping in chronic and genetic disorders detection, advantages of SNP genotyping and strategic initiatives by market players to introduce new products in the market.

Single nucleotide polymorphism (SNP) technologies are extensively utilized for detection and are beneficial in the etiology of several human diseases, such as cancer, cardiovascular, Alzheimer's, and asthma, among others. For instance, an article published in Nature Reviews Bioengineering Journal in March 2023 mentioned that a portable device utilizing a microarray system functionalized with fluorescently quenched toehold probes allows for multiplex single-nucleotide discrimination and enables the typing of single-nucleotide polymorphisms (SNPs). This battery-operated device can also be combined with a toroidal convection chamber for Polymerase chain reaction (PCR), facilitating device miniaturization and point-of-care use. Therefore, the rising applications of SNPs in several aspects of life sciences and biotechnology are driving the SNP genotyping market.

Additionally, the significant advantages of SNP genotyping are likely to promote its adoption, thus fuelling the market growth. For instance, an article published in the Journal of Biosensors (Basel) in September 2023 mentioned that electrochemical SNP biosensors offer several benefits, including affordability, rapid response times, high sensitivity, and ease of miniaturization. These biosensors can detect single-nucleotide polymorphisms (SNPs) associated with various diseases and improve early diagnosis. Thus, due to such advantages, these biosensors are likely to be adopted, contributing to market growth.

Furthermore, the launch of new biological products, acquisitions, collaborations, and regional expansions are some of the strategic initiatives adopted by the companies to maintain stability in the market. For instance, in January 2024, Thermo Fisher Scientific launched the Axiom PangenomiX Array, designed to enhance disease risk and detection research, facilitate population-level disease studies, support ancestry and wellness testing, evaluate drug efficacy, and contribute to drug development research. The PangenomiX Array is integrated with four assays into a single test, which includes SNP genotyping, whole-genome copy number variant detection, fixed copy number discovery, and blood and human leukocyte antigen (HLA) typing. This is likely to fuel market growth in the near future.

Therefore, owing to the above-mentioned factors, such as SNP genotyping applications in disease detection, significant advantages, and product launches, the studied market's growth over the forecast period is collectively responsible. However, the lack of standardization in SNP processes and privacy concerns posing a threat to broad technology applications are the major factors hindering market growth.

SNP Genotyping Industry Overview

The SNP genotyping market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold significant market shares and are well known, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., LGC Group, Douglas Scientific LLC, Illumina Inc., and Luminex Corporation, among others.

SNP Genotyping Market Leaders

  1. Thermo Fisher Scientific Inc.

  2. Agilent Technologies

  3. Bio-Rad Laboratories Inc.

  4. Illumina Inc.

  5. LGC Group

  6. *Disclaimer: Major Players sorted in no particular order
SNP Genotyping Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

SNP Genotyping Market News

  • August 2024: Amoneta Diagnostics SAS received Conformité Européene (CE) marking for its APO-Easy genotyping kit in accordance with the European Union (EU) In Vitro Diagnostic Regulation 2017/746 (IVDR). The APO-Easy Genotyping Kit is a ready-to-use qualitative in vitro diagnostic (IVD) test that utilizes real-time polymerase chain reaction (RT-PCR) for the accurate detection of two single-nucleotide polymorphisms (SNPs): rs429358 and rs7412 associated with Alzheimer's disease.
  • April 2024: Applied BioCode Inc. unveiled its newest product, the BioCode STI + Resistance Panel for research use only (RUO). This multiplex nucleic acid amplification test is specifically designed to qualitatively identify DNA from Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV), and Mycoplasma genitalium (MG), along with macrolide-resistant and fluoroquinolone-resistant single nucleotide polymorphism (SNP) mutations in a single assay.

SNP Genotyping Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Miniaturisation of Equipment and Instruments
    • 4.2.2 Applications of SNP Genotyping in Chronic and Genetic Disease Detection
  • 4.3 Market Restraints
    • 4.3.1 Lack of Standardisation in SNP Processes
    • 4.3.2 Privacy Concerns
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Technology
    • 5.1.1 TaqMan SNP Genotyping
    • 5.1.2 Massarray SNP Genotyping
    • 5.1.3 SNP GeneChip Arrays
    • 5.1.4 Other Technologies
  • 5.2 By Usage
    • 5.2.1 Pharmacogenomics
    • 5.2.2 Diagnostic Field
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies Inc.
    • 6.1.2 Bio-Rad Laboratories Inc.
    • 6.1.3 Douglas Scientific LLC
    • 6.1.4 Illumina Inc.
    • 6.1.5 Luminex Corporation
    • 6.1.6 Promega Corporation
    • 6.1.7 Thermo Fisher Scientific Inc.
    • 6.1.8 Sequenom
    • 6.1.9 PREMIER Biosoft
    • 6.1.10 Standard BioTools
    • 6.1.11 LGC Group
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

SNP Genotyping Industry Segmentation

As per the scope of the report, single-nucleotide polymorphism (SNP) refers to mutations found at a specific locus or single base-pair mutation containing two alleles. SNPs aid in understanding the correlations between the genotype and behavior indicated by all living organisms. The SNP genotyping market is segmented by technology, usage and geography. By technology, the market is segmented into TaqMan SNP genotyping, massarray SNP genotyping, SNP GeneChip arrays, and other technologies. Other technologies include SNP Pyrosequencing, Real-time PCR-based SNP Genotyping and others. By usage, the market is segmented into pharmacogenomics and diagnostic field. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle-East and Africa, and South America. For each segment, the market size is provided in terms of USD value.

By Technology TaqMan SNP Genotyping
Massarray SNP Genotyping
SNP GeneChip Arrays
Other Technologies
By Usage Pharmacogenomics
Diagnostic Field
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

SNP Genotyping Market Research FAQs

How big is the SNP Genotyping Market?

The SNP Genotyping Market size is expected to reach USD 7.44 billion in 2025 and grow at a CAGR of 21.03% to reach USD 19.33 billion by 2030.

What is the current SNP Genotyping Market size?

In 2025, the SNP Genotyping Market size is expected to reach USD 7.44 billion.

Who are the key players in SNP Genotyping Market?

Thermo Fisher Scientific Inc., Agilent Technologies, Bio-Rad Laboratories Inc., Illumina Inc. and LGC Group are the major companies operating in the SNP Genotyping Market.

Which is the fastest growing region in SNP Genotyping Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in SNP Genotyping Market?

In 2025, the North America accounts for the largest market share in SNP Genotyping Market.

What years does this SNP Genotyping Market cover, and what was the market size in 2024?

In 2024, the SNP Genotyping Market size was estimated at USD 5.88 billion. The report covers the SNP Genotyping Market historical market size for years: 2022, 2023 and 2024. The report also forecasts the SNP Genotyping Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

SNP Genotyping Industry Report

The SNP Genotyping and Analysis Market is segmented by technology and end-user, covering a wide range of techniques including TaqMan SNP Genotyping, Massarray SNP Genotyping, and SNP GeneChip Arrays. The market analysis provides a comprehensive industry overview, highlighting the significant growth rate and market trends within this sector. The industry report includes market research and statistics, offering valuable insights into the market size, market share, and market value.

The industry analysis reveals that North America, Europe, Asia-Pacific, Middle-East and Africa, and South America are key regions contributing to the market growth. The market forecast and industry outlook predict continued expansion, driven by advancements in pharmacogenomics and diagnostic fields. The report example and report PDF download offer detailed industry information, including market segmentation and market predictions.

The market review and market data emphasize the role of market leaders in shaping the industry trends and market outlook. The report also covers industry sales and market growth, providing a thorough market overview and industry research. The industry reports and market forecast offer a historical perspective and a forward-looking analysis, ensuring a well-rounded understanding of the SNP Genotyping and Analysis Market.

Overall, this report serves as an essential resource for research companies and stakeholders, offering critical industry statistics and market segmentation details. The report underscores the importance of industry size and market predictions in strategizing for future market opportunities.